img

Global Cancer Anorexia-Cachexia Syndrome Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cancer Anorexia-Cachexia Syndrome Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Cancer Anorexia-Cachexia Syndrome Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cancer Anorexia-Cachexia Syndrome Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cancer Anorexia-Cachexia Syndrome Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cancer Anorexia-Cachexia Syndrome Drug key manufacturers include Acacia Pharma Ltd, Aeterna Zentaris Inc, Aphios Corp, Incyte Corp, Lakewood-Amedex Inc, Novartis AG, Obexia AG, PsiOxus Therapeutics Ltd and RaQualia Pharma Inc, etc. Acacia Pharma Ltd, Aeterna Zentaris Inc, Aphios Corp are top 3 players and held % sales share in total in 2022.
Cancer Anorexia-Cachexia Syndrome Drug can be divided into NEO-1940, C-1889, DLN-101 and Foxo1-nRNA, etc. NEO-1940 is the mainstream product in the market, accounting for % sales share globally in 2022.
Cancer Anorexia-Cachexia Syndrome Drug is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Cancer Anorexia-Cachexia Syndrome Drug industry development. In 2022, global % sales of Cancer Anorexia-Cachexia Syndrome Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cancer Anorexia-Cachexia Syndrome Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Acacia Pharma Ltd
Aeterna Zentaris Inc
Aphios Corp
Incyte Corp
Lakewood-Amedex Inc
Novartis AG
Obexia AG
PsiOxus Therapeutics Ltd
RaQualia Pharma Inc
Viking Therapeutics Inc
Segment by Type
NEO-1940
C-1889
DLN-101
Foxo1-nRNA
AVGN-7
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cancer Anorexia-Cachexia Syndrome Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cancer Anorexia-Cachexia Syndrome Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cancer Anorexia-Cachexia Syndrome Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cancer Anorexia-Cachexia Syndrome Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cancer Anorexia-Cachexia Syndrome Drug introduction, etc. Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cancer Anorexia-Cachexia Syndrome Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Cancer Anorexia-Cachexia Syndrome Drug Market Overview
1.1 Cancer Anorexia-Cachexia Syndrome Drug Product Overview
1.2 Cancer Anorexia-Cachexia Syndrome Drug Market Segment by Type
1.2.1 NEO-1940
1.2.2 C-1889
1.2.3 DLN-101
1.2.4 Foxo1-nRNA
1.2.5 AVGN-7
1.2.6 Others
1.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type
1.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2018-2024)
2 Global Cancer Anorexia-Cachexia Syndrome Drug Market Competition by Company
2.1 Global Top Players by Cancer Anorexia-Cachexia Syndrome Drug Sales (2018-2024)
2.2 Global Top Players by Cancer Anorexia-Cachexia Syndrome Drug Revenue (2018-2024)
2.3 Global Top Players by Cancer Anorexia-Cachexia Syndrome Drug Price (2018-2024)
2.4 Global Top Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cancer Anorexia-Cachexia Syndrome Drug Market Competitive Situation and Trends
2.5.1 Cancer Anorexia-Cachexia Syndrome Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Anorexia-Cachexia Syndrome Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Cancer Anorexia-Cachexia Syndrome Drug Market
2.8 Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cancer Anorexia-Cachexia Syndrome Drug Status and Outlook by Region
3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size by Region
3.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Region (2018-2024)
3.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Region
3.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Region (2024-2034)
3.3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Cancer Anorexia-Cachexia Syndrome Drug by Application
4.1 Cancer Anorexia-Cachexia Syndrome Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application
4.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2018-2024)
5 North America Cancer Anorexia-Cachexia Syndrome Drug by Country
5.1 North America Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size by Country
5.1.1 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Country (2018-2024)
5.2 North America Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Country
5.2.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Country (2024-2034)
6 Europe Cancer Anorexia-Cachexia Syndrome Drug by Country
6.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size by Country
6.1.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Country (2018-2024)
6.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Country
6.2.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug by Region
7.1 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size by Region
7.1.1 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Region (2024-2034)
8 Latin America Cancer Anorexia-Cachexia Syndrome Drug by Country
8.1 Latin America Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size by Country
8.1.1 Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Country (2018-2024)
8.2 Latin America Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Country
8.2.1 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug by Country
9.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size by Country
9.1.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Acacia Pharma Ltd
10.1.1 Acacia Pharma Ltd Company Information
10.1.2 Acacia Pharma Ltd Introduction and Business Overview
10.1.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.1.5 Acacia Pharma Ltd Recent Development
10.2 Aeterna Zentaris Inc
10.2.1 Aeterna Zentaris Inc Company Information
10.2.2 Aeterna Zentaris Inc Introduction and Business Overview
10.2.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.2.5 Aeterna Zentaris Inc Recent Development
10.3 Aphios Corp
10.3.1 Aphios Corp Company Information
10.3.2 Aphios Corp Introduction and Business Overview
10.3.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.3.5 Aphios Corp Recent Development
10.4 Incyte Corp
10.4.1 Incyte Corp Company Information
10.4.2 Incyte Corp Introduction and Business Overview
10.4.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.4.5 Incyte Corp Recent Development
10.5 Lakewood-Amedex Inc
10.5.1 Lakewood-Amedex Inc Company Information
10.5.2 Lakewood-Amedex Inc Introduction and Business Overview
10.5.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.5.5 Lakewood-Amedex Inc Recent Development
10.6 Novartis AG
10.6.1 Novartis AG Company Information
10.6.2 Novartis AG Introduction and Business Overview
10.6.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.6.5 Novartis AG Recent Development
10.7 Obexia AG
10.7.1 Obexia AG Company Information
10.7.2 Obexia AG Introduction and Business Overview
10.7.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.7.5 Obexia AG Recent Development
10.8 PsiOxus Therapeutics Ltd
10.8.1 PsiOxus Therapeutics Ltd Company Information
10.8.2 PsiOxus Therapeutics Ltd Introduction and Business Overview
10.8.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.8.5 PsiOxus Therapeutics Ltd Recent Development
10.9 RaQualia Pharma Inc
10.9.1 RaQualia Pharma Inc Company Information
10.9.2 RaQualia Pharma Inc Introduction and Business Overview
10.9.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.9.5 RaQualia Pharma Inc Recent Development
10.10 Viking Therapeutics Inc
10.10.1 Viking Therapeutics Inc Company Information
10.10.2 Viking Therapeutics Inc Introduction and Business Overview
10.10.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
10.10.5 Viking Therapeutics Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cancer Anorexia-Cachexia Syndrome Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cancer Anorexia-Cachexia Syndrome Drug Industrial Chain Analysis
11.4 Cancer Anorexia-Cachexia Syndrome Drug Market Dynamics
11.4.1 Cancer Anorexia-Cachexia Syndrome Drug Industry Trends
11.4.2 Cancer Anorexia-Cachexia Syndrome Drug Market Drivers
11.4.3 Cancer Anorexia-Cachexia Syndrome Drug Market Challenges
11.4.4 Cancer Anorexia-Cachexia Syndrome Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors
12.3 Cancer Anorexia-Cachexia Syndrome Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of NEO-1940
Table 2. Major Company of C-1889
Table 3. Major Company of DLN-101
Table 4. Major Company of Foxo1-nRNA
Table 5. Major Company of AVGN-7
Table 6. Major Company of Others
Table 7. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2018-2024) & (K Pcs)
Table 9. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2018-2024) & (US& Million)
Table 11. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share in Value by Type (2018-2024)
Table 12. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2024-2034) & (K Pcs)
Table 14. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type (2024-2034)
Table 17. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2018-2024) & (K Pcs)
Table 19. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Company (2018-2024) & (K Pcs)
Table 29. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Company (2018-2024)
Table 30. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Company (2018-2024)
Table 32. Global Market Cancer Anorexia-Cachexia Syndrome Drug Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global Cancer Anorexia-Cachexia Syndrome Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Anorexia-Cachexia Syndrome Drug as of 2022)
Table 36. Date of Key Manufacturers Enter into Cancer Anorexia-Cachexia Syndrome Drug Market
Table 37. Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2018-2024) & (K Pcs)
Table 41. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Region (2018-2024)
Table 44. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2024-2034) & (K Pcs)
Table 46. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Region (2024-2034)
Table 49. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) & (K Pcs)
Table 52. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application (2018-2024)
Table 55. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2024-2034) & (K Pcs)
Table 57. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application (2024-2034)
Table 60. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 62. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2018-2024) & (K Pcs)
Table 72. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Country (2018-2024)
Table 75. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2024-2034) & (K Pcs)
Table 76. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Country (2024-2034)
Table 111. Acacia Pharma Ltd Company Information
Table 112. Acacia Pharma Ltd Introduction and Business Overview
Table 113. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product
Table 115. Acacia Pharma Ltd Recent Development
Table 116. Aeterna Zentaris Inc Company Information
Table 117. Aeterna Zentaris Inc Introduction and Business Overview
Table 118. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product
Table 120. Aeterna Zentaris Inc Recent Development
Table 121. Aphios Corp Company Information
Table 122. Aphios Corp Introduction and Business Overview
Table 123. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product
Table 125. Aphios Corp Recent Development
Table 126. Incyte Corp Company Information
Table 127. Incyte Corp Introduction and Business Overview
Table 128. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product
Table 130. Incyte Corp Recent Development
Table 131. Lakewood-Amedex Inc Company Information
Table 132. Lakewood-Amedex Inc Introduction and Business Overview
Table 133. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product
Table 135. Lakewood-Amedex Inc Recent Development
Table 136. Novartis AG Company Information
Table 137. Novartis AG Introduction and Business Overview
Table 138. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product
Table 140. Novartis AG Recent Development
Table 141. Obexia AG Company Information
Table 142. Obexia AG Introduction and Business Overview
Table 143. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product
Table 145. Obexia AG Recent Development
Table 146. PsiOxus Therapeutics Ltd Company Information
Table 147. PsiOxus Therapeutics Ltd Introduction and Business Overview
Table 148. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product
Table 150. PsiOxus Therapeutics Ltd Recent Development
Table 151. RaQualia Pharma Inc Company Information
Table 152. RaQualia Pharma Inc Introduction and Business Overview
Table 153. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 154. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product
Table 155. RaQualia Pharma Inc Recent Development
Table 156. Viking Therapeutics Inc Company Information
Table 157. Viking Therapeutics Inc Introduction and Business Overview
Table 158. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 159. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product
Table 160. Viking Therapeutics Inc Recent Development
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Cancer Anorexia-Cachexia Syndrome Drug Market Trends
Table 164. Cancer Anorexia-Cachexia Syndrome Drug Market Drivers
Table 165. Cancer Anorexia-Cachexia Syndrome Drug Market Challenges
Table 166. Cancer Anorexia-Cachexia Syndrome Drug Market Restraints
Table 167. Cancer Anorexia-Cachexia Syndrome Drug Distributors List
Table 168. Cancer Anorexia-Cachexia Syndrome Drug Downstream Customers
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Anorexia-Cachexia Syndrome Drug Product Picture
Figure 2. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of NEO-1940
Figure 6. Global NEO-1940 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of C-1889
Figure 8. Global C-1889 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of DLN-101
Figure 10. Global DLN-101 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Foxo1-nRNA
Figure 12. Global Foxo1-nRNA Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of AVGN-7
Figure 14. Global AVGN-7 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2022 & 2034
Figure 19. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 20. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 21. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 22. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 25. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Anorexia-Cachexia Syndrome Drug Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Anorexia-Cachexia Syndrome Drug Revenue in 2022
Figure 31. Cancer Anorexia-Cachexia Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2022 & 2034
Figure 40. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application in 2022
Figure 41. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 42. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application in 2022
Figure 43. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 46. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Cost Structure
Figure 51. Cancer Anorexia-Cachexia Syndrome Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries